Copenhagen University Hospital Rigshospitalet
Denmark
Contact Information for physicians and patients
direktionen.rigshospitalet(at)regionh.dk
Particular rare liver disease expertise of the centre
Acute liver failure and replacement therapy. Autoimmune liver disease:
- Primary Biliary Cholangitis (PBC)
- Autoimmune Hepatitis (AIH)
- Primary Sclerosing Cholangitis (PSC)
Genetics and metabolic liver diseases.
Biliary atresia/cholestatic liver diseases.
Both pediatric and adult hepatology.
ERN Representatives
-
Marianne Hørby Jørgensen
Rigshospitalet (RH), Copenhagen university hospital
- Representatives of the hepatology societies (EASL & ESPGHAN)
ESPGHAN Representative
-
Henriette Ytting
MD PhD senior consultant, adult hepatologist
Hvidovre University Hospital
ERN Team and Contact
direktionen.rigshospitalet(at)regionh.dk
direktionen.hvidovrehospital(at)regionh.dk
Centre information
Rigshospitalet (RH), Copenhagen University Hospital, is the main tertiary hospital in Denmark and the national center for liver transplantation. Rigshospitalet is the main center for managing acute liver failure, metabolic liver diseases, severe decompensated liver cirrhosis, biliary atresia and liver cancers such as hepatoblastoma, cholangiocarcinoma and hepatocellular carcinoma.
RH has a highly specialized clinical team of hepatologists, pediatricians and surgeons within adult as well as pediatric liver care, also including intensive care units (both NICU, PICU and ICU). Furthermore, adult and pediatric hepatologists have a well-established collaboration with a broad network of paraclinical staff in radiology, pathology, genetics, immunology and metabolic experts with special expertise in hepatology.
For the adult hepatology a collaborative agreement has been formed with Hvidovre University Hospital which participates in the ERN RARE-LIVER work. Hvidovre University Hospital has highly specialized functions including autoimmune liver diseases in collaboration with Rigshospitalet and within the areas portal hypertension, cirrhosis-related complications with failure of standard treatment including TIPS and management of cirrhosis of unknown etiology.
